CARUBBI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 6.512
EU - Europa 3.382
AS - Asia 949
AF - Africa 16
SA - Sud America 14
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.883
Nazione #
US - Stati Uniti d'America 6.489
GB - Regno Unito 1.308
IT - Italia 715
SE - Svezia 376
DE - Germania 354
CN - Cina 307
HK - Hong Kong 202
TR - Turchia 179
UA - Ucraina 178
SG - Singapore 165
FI - Finlandia 120
FR - Francia 108
BG - Bulgaria 81
IN - India 28
CA - Canada 21
ID - Indonesia 21
RO - Romania 20
BE - Belgio 18
RU - Federazione Russa 16
IE - Irlanda 14
NL - Olanda 13
IR - Iran 12
EG - Egitto 11
LT - Lituania 11
CZ - Repubblica Ceca 10
QA - Qatar 8
VN - Vietnam 8
ES - Italia 7
MY - Malesia 7
AU - Australia 5
GR - Grecia 5
MK - Macedonia 5
PL - Polonia 5
CH - Svizzera 4
CO - Colombia 4
EU - Europa 4
PH - Filippine 4
SI - Slovenia 4
SA - Arabia Saudita 3
AT - Austria 2
BO - Bolivia 2
BR - Brasile 2
BZ - Belize 2
CL - Cile 2
EC - Ecuador 2
JP - Giappone 2
PE - Perù 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
DK - Danimarca 1
ET - Etiopia 1
KR - Corea 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 10.883
Città #
Southend 1.062
Fairfield 889
Chandler 659
Woodbridge 641
Ashburn 493
Houston 434
Jacksonville 389
Seattle 340
Wilmington 326
Cambridge 320
Dearborn 297
Ann Arbor 255
Nyköping 243
Hong Kong 198
Modena 124
Beijing 113
Singapore 110
Izmir 108
San Diego 102
Princeton 92
Bremen 83
Sofia 81
Eugene 70
Grafing 61
Helsinki 58
New York 57
Des Moines 56
Falls Church 41
London 34
Milan 34
Reggio Emilia 27
Shanghai 25
Rome 24
Bologna 23
Jakarta 21
Parma 21
Redwood City 19
Brussels 18
Nanjing 18
Boardman 17
Timisoara 15
Norwalk 14
Fremont 13
Verona 12
Dublin 11
Frankfurt am Main 11
Guangzhou 11
Ottawa 11
Abbiategrasso 10
Hefei 10
Kunming 9
Munich 9
Phoenix 9
Doha 8
Dong Ket 8
Florence 8
Los Angeles 8
Auburn Hills 7
Jinan 7
Mumbai 7
Padova 7
Brno 6
Dallas 6
Genova 6
Hounslow 6
Kilburn 6
Monza 6
San Mateo 6
Santeramo in Colle 6
Shenyang 6
Turin 6
Wuhan 6
Amsterdam 5
Brescia 5
Formia 5
Leawood 5
Manchester 5
Palermo 5
Pisa 5
Barcelona 4
Bari 4
Bobbio 4
Ferrara 4
Marcianise 4
Nanchang 4
Naples 4
Paris 4
Ravenna 4
Rho 4
Washington 4
Ankara 3
Arienzo 3
Avigliano 3
Busto Arsizio 3
Cagliari 3
Catania 3
Chiswick 3
Hebei 3
Islington 3
Maddaloni 3
Totale 8.363
Nome #
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 373
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 263
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 249
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 221
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 216
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 216
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 209
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 205
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 205
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 190
Growth of human herpesvirus 6 in HepG2 cells 185
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 184
Management of bone disease in Gaucher disease type 1: clinical practice 182
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 178
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 177
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 171
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 170
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 168
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 166
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 163
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 162
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 162
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 161
Cholesterol esterase activity of human intestinal mucosa 159
Fabry disease: raising awareness of the disease among physicians 158
Review article: effect of bile salt pool composition on hepatic and biliary functions 155
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 154
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 150
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 145
Minimal disease activity in Gaucher disease: criteria for definition 145
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 143
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 140
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 137
Nonalcoholic fatty liver disease induced by leuprorelin acetate 135
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 134
Anatomia e fisiologia delle vie biliari 132
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 132
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 131
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 128
Cholesterol Esterase Activity of human intestinal mucosa 127
Bile acid structure and regulation of biliary protein secretion and composition in man 126
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 125
Cholesterol esterase activity of human intestinal mucosa 123
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 122
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 118
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 117
Regulation of cholesterol absorption in humans 117
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 115
Hyperferritinemia and diagnosis of type 1 Gaucher disease 112
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 109
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 108
Patogenesi della colelitiasi 107
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 103
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 102
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 99
Prevalence rates of gallstone disease in Italy: the Chianciano population study 95
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 91
Gaucher Disease in Bone: From Pathophysiology to Practice 91
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 90
Nuove prospettive terapeutiche con acidi biliari. 88
Bile acid and hepatocyte death 87
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 87
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 86
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 85
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 84
Inquadramento delle sindromi colestatiche. 84
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 84
Malattie delle vie biliari 82
Regulation of bile acid synthesis in humans 82
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 82
Cholesterol esterase activity in the small bowel of humans 80
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 80
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 79
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 75
Nutrition in adult patients with selected lysosomal storage diseases 75
LA SECREZIONE LIPIDICA BILIARE 72
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 72
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 72
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 62
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 59
Global multi-stakeholder endorsement of the MAFLD definition 56
Liver metastases from carcinoid tumor: Imaging patterns 52
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 52
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 36
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 20
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 19
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 14
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 14
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 13
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 9
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 7
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 5
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 2
Totale 11.007
Categoria #
all - tutte 45.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.924 0 150 93 113 189 330 387 199 177 85 115 86
2020/20211.886 139 56 117 168 147 84 352 317 93 206 106 101
2021/20221.764 89 202 125 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/2025172 134 38 0 0 0 0 0 0 0 0 0 0
Totale 11.007